SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL)
IMCL 0.1590.0%Oct 5 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: flickerful who wrote (227)1/20/1999 7:43:00 AM
From: CPAMarty  Read Replies (1) of 2515
 
Q & A with Andrea R. at IMCL IR

1.The latest PR indicates that; The late stage equity-based milestones are to be paid through the purchase of common stock of ImClone at a premium to the then market price.
What specifically will this premium be?

The premium is based on a range but it can be as high as 50% above were the stock is trading at the time of the milestone being achieved.

2.Analysts
I noticed IMCL presented at H&Q's annual health science conference.
a) What was the general reaction to the presentation? Did H&Q have anything to say?
b) Has H&Q written a summary of the presentations, now that the conference is over?
c) Has, or do you expect, H&Q to do a write up on IMCL itself?
d) can you send me a copy of what IMCL presented and any feedback/commentary about IMCL's products and presentation?
e) Has IMCL met with any other analysts (like Franklin Berger who covered IMCL at ? (Smith Barney) but who recently left for J P Morgan) in the past few months? expect to speak to any in next few months?

The ImClone presentation at H&Q was well received by those
investors who spoke with me after the presentation. At the present time the analyst at H&Q does not cover the company. We do plan to meet with them but at the present time I cannot say whether they will be initiating coverage on the company. You would need to contact H&Q to find out if they have summaries of the corporate presentations. They may also have tapes available of the presentations. We do have a copy of the slides, however without it be presented it may not be the most valuable thing to send since it needs the oral presentation. The company has actively been pursuing and meeting with various sell side analyst over the past few months. At this time I cannot say when coverage will be initiated. It is not appropriate for me to hypothesize on when this may
happen and who the analyst may be.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext